Literature DB >> 12505262

Cryptic t(X;18), ins(6;18), and SYT-SSX2 gene fusion in a case of intraneural monophasic synovial sarcoma.

Valia S Lestou1, John X O'Connell, Marc Robichaud, Charis Salski, Joan Mathers, John Maguire, Ilse Chudoba, Poul H B Sorensen, Wan Lam, Douglas E Horsman.   

Abstract

A 54-year-old male presented with a spontaneous peroneal nerve palsy and a diagnosis of monophasic synovial sarcoma (SS) was rendered by histologic examination. Cytogenetic analysis revealed a complex abnormal karyotype without evidence of the typical t(X;18)(p11;q11) associated with SS. Subsequent reverse transcriptase polymerase chain reaction analysis showed the presence of an SYT/SSX2 fusion transcript, confirming the presence of a cyptic t(X;18). In light of -X, -18 and marker chromosomes evident in the G-band karyotype, it was suspected that a cryptic chromosomal rearrangement involving the marker chromosomes would harbor an X;18 fusion. Multi-colored karytotyping (M-FISH) revealed a previously unrecognized t(X;18) and t(5;19) in the marker chromosomes as well as unrecognized ins(6;18) and t(16;20). The addition of M-FISH analysis in this case led to the identification of complex inter-chromosomal rearrangements, thus providing an accurate karyotype.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12505262     DOI: 10.1016/s0165-4608(02)00583-6

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  3 in total

1.  Synovial Sarcoma of the Nerve-Clinical and Pathological Features: Case Series and Systematic Review.

Authors:  Stephen Shelby Burks; Ross C Puffer; Iahn Cajigas; David Valdivia; Andrew E Rosenberg; Robert J Spinner; Allan D Levi
Journal:  Neurosurgery       Date:  2019-12-01       Impact factor: 4.654

2.  Intraneural synovial sarcoma of the median nerve.

Authors:  Angelo B Lipira; Rahul Kasukurthi; Wilson Z Ray; Mark E Pruzansky; Susan E Mackinnon
Journal:  Rare Tumors       Date:  2010-06-30

3.  Immunohistochemical validation of TLE1, a novel marker, for synovial sarcomas.

Authors:  Bharat Rekhi; Ranjan Basak; Sangeeta B Desai; Nirmala A Jambhekar
Journal:  Indian J Med Res       Date:  2012-11       Impact factor: 2.375

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.